IL1B and autoimmune disease: These data indicate that CCN1 is a mediator of IL-1β production in psoriasis and plays a critical role in regulating inflammation in psoriasis, suggesting that CCN1 could be a potential target for clinical treatment of inflammatory and autoimmune diseases, such as psoriasis.